Skip to content

Drug interactions

Osimertinib + Siponimod

Severity: Major

Osimertinib and Siponimod: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can affect cardiac conduction, since osimertinib prolongs the QT interval and siponimod slows heart rate. Together they may increase the risk of bradycardia-related arrhythmia such as torsades de pointes.

What this interaction means in plain words

Osimertinib and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Osimertinib belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive QT prolongation combined with siponimod-induced bradycardia.

What to do

Obtain a baseline ECG and monitor it, and correct potassium and magnesium. Seek cardiology advice before starting siponimod.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Osimertinib and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Osimertinib with Siponimod?

MediHelp rates the interaction as major. Osimertinib and Siponimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs can affect cardiac conduction, since osimertinib prolongs the QT interval and siponimod slows heart rate. Together they may increase the risk of bradycardia-related arrhythmia such as torsades de pointes.

How serious is the interaction between Osimertinib and Siponimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor it, and correct potassium and magnesium. Seek cardiology advice before starting siponimod.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in